Status:
RECRUITING
GWA Study in Patients With Inflammatory Bowel Disease
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowe...
Detailed Description
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the gut that cause major life-long disability. Afflicting mostly young people at an age when they are most active...
Eligibility Criteria
Inclusion
- Age 18 or above
- Informed consent given by patient or family
- Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology
- Control group (non-IBD cases) Ethically, sex and aged-matched controls attending clinics or endoscopy for functional upper gastrointestinal diseases or screening colonoscopy.
Exclusion
- No consent
- Controls will be excluded if they have previously been diagnosed with IBD or if they have a first or second degree relative with IBD.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2037
Estimated Enrollment :
3600 Patients enrolled
Trial Details
Trial ID
NCT01140789
Start Date
April 1 2010
End Date
April 1 2037
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong